Carvolix SA (EPA:CVX)
France · Delayed Price · Currency is EUR 5.64
-0.14 (-2.42%)
Oct 5, 2026, 5:35 PM CET
Carvolix Market Cap
Carvolix has a market cap or net worth of €334.13 million as of October 5, 2026. Its market cap has increased by 473.76% in one year.
Market Cap
334.13M
Enterprise Value
356.42M
Revenue
1.59M
Ranking
n/a
PE Ratio
n/a
Stock Price
€5.64
ChartMarket Cap Chart
Since June 14, 2021, Carvolix's market cap has increased from 145.31M to 334.13M, an increase of 129.95%. That is a compound annual growth rate of 16.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 334.13M | 390.85% |
| Dec 31, 2025 | 68.07M | 28.15% |
| Dec 31, 2024 | 53.12M | -6.82% |
| Dec 29, 2023 | 57.01M | 86.82% |
| Dec 30, 2022 | 30.52M | -70.47% |
| Dec 31, 2021 | 103.35M | -28.88% |
| Jun 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eurobio Scientific Société anonyme | 252.71M |
| Median Technologies | 123.27M |
| Guerbet | 84.27M |
| Theraclion | 48.40M |
| Novacyt | 32.63M |
| Mauna Kea Technologies | 23.95M |
| Diagnostic Medical Systems | 23.85M |
| Ikonisys | 23.29M |